Advertisement

Topics

NextCure's IPO nets $69.75mm

15:40 EDT 10 May 2019 | Elsevier Business Intelligence

Immunotherapy firm NextCure Inc. netted $69.75mm through its initial public offering of 5mm common shares at $15, the midpoin...

Original Article: NextCure's IPO nets $69.75mm

NEXT ARTICLE

More From BioPortfolio on "NextCure's IPO nets $69.75mm"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...